Skip to main content
. 2021 Jun 25;87(14):e02980-20. doi: 10.1128/AEM.02980-20

TABLE 4.

Plasmid characteristics and plasmid-borne resistance genes in 25 transconjugants using Miseq/MinION sequencing platforms

Plasmid ID Resistance genes on the plasmidb,c Farm/sample type Inc groupd,e Plasmid size (bp) Predicted mobility Predicted resistance phenotypef
pT82Aa aac (6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 4/raw Inc− 104,812 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT101Aa aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 4/raw Inc− 104,812 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT159Aa aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 1/digested Inc− 104,812 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT209Aa aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 7/digested Inc− 104,864 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT267Aa aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 5/raw Inc− 104,864 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT270Aa aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 5/raw Inc− 104,864 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT221A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 7/digested Inc− ∼96,702 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT286A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 2/raw Inc− ∼96,702 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT496A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 5/raw Inc− ∼96,702 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT304A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 3/raw Inc− ∼96,702 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT306A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 3/raw Inc− ∼96,702 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT409A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 7/digested Inc− ∼96,702 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT478A aac(6′)-Ib-cr, aph(3′')-Ib, aph(6)-Id, blaCTX-M-15, blaOXA-1, catB4, dfrA1, floR, lnu(G), sul2 Farm 4/raw Inc− ∼96,650 Conjugative Cip Gen Str Kan Amp Axo Tmp Chl Lin Sxz
pT145A blaCTX-M-15 Farm 1/raw IncI1 ∼85,051 Conjugative Amp Axo
pT277A blaCTX-M-15 Farm 1/raw IncI1 ∼83, 223 Conjugative Amp Axo
pT308A blaCTX-M-14 Farm 3/raw IncI1 ∼94,724 Conjugative Amp Axo
pT247Aa blaCTX-M-14 Farm 2/raw IncI1 91,905 Conjugative Amp Axo
pT199Aa blaCTX-M-1 Farm 7/raw IncN 42,578 Conjugative Amp Axo
pT257Aa blaCTX-M-27 Farm 2/digested IncFIIA, IncFII 66,581 Conjugative Amp Axo
pT455A blaCTX-M-27 Farm 2/digested IncN ∼41,970 Conjugative Amp Axo
pT295Aa aph(3′')-Ib, aph(6)-Id, blaCTX-M-27, blaTEM-1B, dfrA14, sul2, tet(A) Farm 2/digested IncN, IncX1 77,311 Conjugative Str Kan Amp Axo Tmp Sxz Tet
pT476A blaCTX-M-55, blaTEM-1B Farm 7/digested IncX1 ∼40,307 Conjugative Amp Axo
pT224Aa blaCTX-M-55, blaTEM-206, fosA3 Farm 7/digested IncFIIA, IncFII 70,625 Conjugative Amp Axo Fos
pT156Aa blaCTX-M-55, blaTEM-206 Farm 1/digested IncFIIA, IncFII 61,659 Conjugative Amp Axo
pT413Aa aadA2, blaPER-1, sul1g, tet(E), tet(X), mph(E), msr(E), aph(3′)-Ia, tet(C) Farm 5/raw IncC 187,012 Conjugative Str Amp Axo Ery Azi
a

Samples were sequenced on both Miseq and MinION platforms, followed by hybrid assembly. These plasmids had complete closed sequences of precise sizes.

b

Genes in bold were identified as ESBL genes.

c

Resistance genes were identified by starAMR tool.

d

Inc group, plasmid size, and predicted mobility were determined by whole-genome sequencing and the MOB-suite tool.

e

Inc−, plasmid with no detectable Inc type.

f

Cip, ciprofloxacin; Gen, gentamicin; Str, streptomycin; Amp, ampicillin; Axo, ceftriaxone; Tmp, trimethoprim; Chl, chloramphenicol; Lin, lincomycin; Sxz, sulfisoxazole; Ery, erythromycin; Azi, azithromycin; Tet, tetracycline; Fos, fosfomycin.

g

This plasmid had two copies of the sul1 gene.